NEPH nephros.com: Price-to-Projected Revenue Ratio

Public company logo of Nephros (NEPH)

Nephros, Inc. (NEPH) specializes in implementing ultra-fine filtration systems to eradicate hospital-acquired infections. The company is scaling B2B deliveries of precision equipment to the US medical and food sectors. Stringent FDA hygiene requirements create a significant barrier to entry for competitors. The trend of the expected P/S allows for an assessment of market expectations, while 1.10 expresses the current value of the metric.

NEPH (Nephros) Price to Expected Revenue Ratio history from 07/04/2022 to 11/13/2026

NEPH (Nephros Corporation): analytical breakdowns and indicator data

- current price and projected stock value:
- company stock capitalization data:
Fundamental valuation:Nephros NEPH
Product sample of Nephros, Inc.

This indicator reflects the dynamics of the ratio between the current market value of Nephros, Inc. (NEPH) and expected sales volume, allowing for the determination of fair business valuation boundaries in real time. By analyzing the projected P/S multiple, an investor can correlate market optimism with the adoption rates of high-tech water filtration systems, identifying either undervalued assets or the risk of excessive overvaluation of the company.